2 Adverse Cancer Studies – New York Times
In one report, researchers analyzed 26 randomized studies involving more than 73,000 patients and concluded that statins like Lipitor and Zocor had no effect on the risk of developing or dying from any form of cancer. Those findings appear Wednesday in JAMA, The Journal of the American Medical Association.

The other study, in the current Journal of the National Cancer Institute, found that cholesterol-lowering drugs, including statins, were of no benefit in preventing colorectal cancer.